Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the international COVID-19 thrombosis biomarkers colloquium

DA Gorog, RF Storey, PA Gurbel, US Tantry… - Nature Reviews …, 2022 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) predisposes patients to thrombotic and
thromboembolic events, owing to excessive inflammation, endothelial cell activation and …

Baseline thrombocytopenia and disease severity among COVID-19 patients, tibebe ghion specialized hospital COVID-19 treatment center, Northwest Ethiopia

F Asrie, E Tekle, Y Gelaw, M Dagnew… - Journal of Blood …, 2022 - Taylor & Francis
Background Thrombocytopenia and platelet indices in COVID-19 patients were important for
prompt treatment and management of the disease. Therefore, the main objective of this …

A hybrid feature selection approach to screen a novel set of blood biomarkers for early COVID-19 mortality prediction

AH Syed, T Khan, N Alromema - Diagnostics, 2022 - mdpi.com
The increase in coronavirus disease 2019 (COVID-19) infection caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has placed pressure on healthcare …

Thyroid hormones and platelet activation in COVID-19 patients

E Colonnello, A Criniti, E Lorusso, M Curreli… - Journal of …, 2023 - Springer
Purpose To retrospectively describe the association between thyroid hormones (TH) and
platelet activation, as represented by mean platelet volume (MPV), in a cohort of patients …

A composite ranking of risk factors for COVID-19 time-to-event data from a Turkish cohort

A Ulgen, S Cetin, M Cetin, H Sivgin, W Li - Computational Biology and …, 2022 - Elsevier
Having a complete and reliable list of risk factors from routine laboratory blood test for
COVID-19 disease severity and mortality is important for patient care and hospital …

Predictors of mortality of hospitalized COVID-19 pneumonia patients in university hospital

SM Wafy, MO Saman, MK Ahmed - The Egyptian Journal of Bronchology, 2024 - Springer
Introduction COVID-19 pneumonia is a leading cause for worse outcome of infected
patients. Factors associated with mortality in COVID-19 pneumonia vary among studies; …

COVID-19 severity and risk factors in Iranian patients with rheumatic diseases

F Akbari Kamrani, N Kianmehr, V Moradians… - Rheumatology …, 2023 - rheumres.org
Since the beginning of COVID-19 pandemic, there was a concern whether patients with
rheumatic diseases are at increased risk of severe COVID-19 in terms of the multi-system …

Analisis Korelasi Jumlah Trombosit dengan Nilai Mean Platelet Volume to Platelet Count Ratio (MPR) pada Pasien Covid-19

PRA Sangging, R Graharti… - … Profession Journal of …, 2023 - journalofmedula.com
Abstract Coronavirus disease 2019 (Covid-19) is an infectious disease caused by SARS-
CoV-2. The number of Covid-19 cases in Indonesia until November 2022 reached 6.7 …

ANALYSES ON CITRULLINATED HISTONE H3(CIT-H3) AND THROMBOCYTE INDEX AS PREDICTOR OF DECREMENT OF PAO2/FIO2 RATIO AND MORTALITY …

HH Pramono, J Nugraha… - Biochemical & Cellular …, 2022 - search.ebscohost.com
Severe COVID-19 has high mortality because cytokin storm will causes Neutrophil
Extracellular Trap (NET) and thrombocyte activation .NET could damage alveolar tissue …

[图书][B] Гиперкоагуляция

В Погорелов, Б Уртаев, Д Проценко, Р Симанин - 2022 - books.google.com
Известно, что болезнь может проявляться избыточным адаптационным ответом
организма на некоторые факторы внутренней или внешней среды. Решающую роль в …